Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,833,800
  • Shares Outstanding, K 481,820
  • Annual Sales, $ 5,307 M
  • Annual Income, $ 864,000 K
  • 36-Month Beta 1.01
  • Price/Sales 7.90
  • Price/Cash Flow 29.71
  • Price/Book 21.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.77
  • Number of Estimates 5
  • High Estimate 0.79
  • Low Estimate 0.75
  • Prior Year 0.65
  • Growth Rate Est. (year over year) +18.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.40 +2.89%
on 10/11/18
94.31 -5.74%
on 10/03/18
+0.11 (+0.12%)
since 09/12/18
3-Month
83.25 +6.79%
on 07/25/18
94.31 -5.74%
on 10/03/18
+3.43 (+4.01%)
since 07/12/18
52-Week
63.03 +41.04%
on 10/30/17
94.31 -5.74%
on 10/03/18
+23.99 (+36.96%)
since 10/12/17

Most Recent Stories

More News
Zoetis Declares Fourth Quarter 2018 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2018 dividend payable to holders of the company's common stock of $0.126 per share. The dividend is to...

ZTS : 88.90 (+2.18%)
JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 158.82 (+2.21%)
ZTS : 88.90 (+2.18%)
After Yesterday's Rally of 1.94% Shares Could Potentially Pullback

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $92.20 to a high of $94.31. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $92.09...

ZTS : 88.90 (+2.18%)
The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis

The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis

CYDY : 0.5400 (-0.63%)
ZTS : 88.90 (+2.18%)
INFI : 2.39 (+3.02%)
NKTR : 48.91 (+2.11%)
CSBR : 11.94 (-3.24%)
5 Best Biotech Stocks to Buy In October

Successful drug trials at several biopharmas and FDA approvals make biotech companies a strong investment choice in October

SRPT : 130.50 (+6.96%)
AGN : 183.28 (+0.58%)
INFI : 2.39 (+3.02%)
VKTX : 14.46 (+4.25%)
CYDY : 0.5400 (-0.63%)
AMRN : 19.65 (+1.76%)
ZTS : 88.90 (+2.18%)
MDGL : 191.64 (+2.12%)
ACAD : 21.72 (+3.48%)
GILD : 73.59 (+1.50%)
ALXN : 121.94 (+2.20%)
CSBR : 11.94 (-3.24%)
NKTR : 48.91 (+2.11%)
Zoetis to Host Webcast and Conference Call on Third Quarter 2018 Financial Results

Zoetis Inc.(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 1, 2018. Chief Executive Officer Juan Ramon Alaix and Executive Vice President and...

ZTS : 88.90 (+2.18%)
Zoetis Named a Top Company for Working Mothers

--Roni Thebo named Zoetis' 2018 Working Mother of the Year

ZTS : 88.90 (+2.18%)
Zoetis to Participate in the 2018 Cantor Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the 2018 Cantor Global Healthcare Conference on Monday, Oct. 1, 2018, in New York, N.Y. Clint Lewis, Executive Vice President and Group President,...

ZTS : 88.90 (+2.18%)
SmarTrend Watching for Potential Pullback in Shares of Zoetis Inc After 1.34% Gain

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $89.32 to a high of $90.50. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $89.69...

ZTS : 88.90 (+2.18%)
Eli Lilly Prices Animal Health Unit IPO at $24 Per Share

Lilly (LLY) prices Elanco IPO at $24 per share which is above the expected range of $20-$23 per share.

LLY : 110.48 (+2.38%)
ZTS : 88.90 (+2.18%)
NVS : 82.78 (+0.71%)
PFE : 43.78 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 90.27
1st Resistance Point 89.58
Last Price 88.90
1st Support Level 87.90
2nd Support Level 86.91

See More

52-Week High 94.31
Last Price 88.90
Fibonacci 61.8% 82.36
Fibonacci 50% 78.67
Fibonacci 38.2% 74.98
52-Week Low 63.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar